Company News

      • October  2018               Semorex CSO, Bernard Green, was invited to speak about “Molecularly Imprinted Polymers” at the Workshop “Functional Polymers for Human Health”, to be held at the Israel Institute for Advanced Studies, Hebrew University, Jerusalem, Israel.
      • March   2018                 Semorex CSO, Bernard Green presented an invited lecture at the 4th Outsourcing in the Clinical Trials Conference, Tel Aviv, Israel.
      • February 2017               Semorex CSO, Bernard Green presented a lecture entitled "Platform Technology for Protein Imprinted Polymers: Novel Approach for Treatment of Inflammatory Bowel Diseases" at the 7th Annual MDDMI - Conference and Exhibition for the Medical Device Design, Manufacturing & Innovation, Tel Aviv, Israel.
      • January 2017                 Semorex senior chemist, Rina Arad Yellin, presented a lecture entitled "New, Reliable Routes to Protein Imprinted Polymers” in IISER, Pune, India.
      • June    2016                  Semorex CSO, Bernard Green presented an Invited Lecture entitled, “A novel, step-wise approach to protein-imprinted polymers (a guide for the perplexed protein imprinter)” at the 9th international Conference on Molecular Imprinting, Lund, Sweden.
      • March  2016                 Semorex CSO, Bernard Green presented an Invited Lecture entitled, “Novel Diagnostic for Invasive Fungal Diseases (IFD)” at the Outsourcing in Clinical Trials Israel 2016 meeting, Tel Aviv, Israel.
      • February 2016               Semorex senior biologist, David Dweck presented a lecture entitled “New, Reliable Routes to Protein Imprinted Polymers” at the ICS 81 – Annual meeting of the Israeli Chemical Society, Tel-Aviv, Israel.
      • December 2015             A Seal of Excellence Certificate was awarded to Semorex Technologies Ltd. for project proposal 712584, “Egro4IFD: Rapid Systemic Invasive Fungal Diseases Diagnosis using Ergosterol”, submitted under the Horizon 2020 SME Instrument Phase 2 Call (H2020-SMEINST-2-2015) 17 September 2015, in the area of Clinical research for the validation of biomarkers and/or diagnostic medical devices.
      • December 2015             Semorex Technologies Ltd. was awarded a one-year grant by the Office of Chief Scientist, Ministry of Economy (Tnufa-Program) in cooperation with MASHAV (Israel’s Agency for International Development Cooperation; Ministry of Foreign Affairs) to pursue the project, “ErgoLFA: Novel Diagnostic Tool for ‘Hidden Killer’, Invasive Fungal Infection”. The proposal was submitted by Semorex researchers Bernard Green and Rina Arad-Yellin, Semorex Associate, Idan Bodaker and Semorex Consultant, Michael Giladi, MD, Sourasky Medical Center, Tel Aviv.
      • November 2015        An US Provisional Patent Application No. 62/254,301 entitled “PROTEIN IMPRINTED POLYMERS” was filed to cover the novel approaches developed by Semorex for the preparation and characterization of such polymers and selected applications. The Inventors are: Bernard S. Green, David Dweck Rina Arad-Yellin, Ori Cohavi, and Doron Eren.
      • November 2015             Semorex CSO, Bernard Green presented an Invited Lecture entitled, “Protein Imprinted Polymers. What’s The Problem Here?” at the EFMC-ASMC’15 - European Federation of Medicinal Chemistry International Symposium on Advances in Synthetic and Medicinal Chemistry, Rehovot, Israel.
      • March 2015                   Semorex Technologies Ltd. was awarded a one-year grant by the Office of Chief Scientist, Ministry of Economy, as part of the Eureka (Bilateral Cooperation Program Hungary-Israel) program. The project “PIP-4-CD: TNFa– binding Polymers for Oral Delivery Therapy in Crohn’s Disease” is conducted in collaboration with Dr. Tamas Letoha of Pharmacoidea, Szeged, Hungary. The Semorex Technologies team includes Bernard Green, Rina Arad-Yellin, and David Dweck.